gi-hepatology
Kruis Score for Diagnosis of Irritable Bowel Syndrome
Validated clinical scoring system for the diagnosis of IBS in primary and secondary care. Uses symptom items and alarm feature exclusions. Originally described by Kruis et al. 1984. Positive score (above 44) has sensitivity ~75-78% and specificity ~85% for IBS diagnosis. Useful to differentiate IBS from organic GI disease. Has been largely superseded by Rome IV criteria but remains in clinical use.
References
- Kruis W et al. A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology. 1984;87(1):1-7.
- NICE NG12. Suspected cancer: recognition and referral. NICE. 2015 (updated 2023). Colorectal cancer section.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Manning Criteria for Irritable Bowel Syndrome · Functional GI Disorders
- Rome IV Diagnostic Criteria for Functional Dyspepsia · Functional GI Disorders
- Rome IV Diagnostic Criteria for Functional Constipation · Functional GI Disorders
- Rome IV Diagnostic Criteria for Functional Chest Pain · Functional GI Disorders
- Rome IV Diagnostic Criteria for Globus · Functional GI Disorders
- Rome IV Diagnostic Criteria for Cyclic Vomiting Syndrome (CVS) · Functional GI Disorders
Drugs
- Risperidone (Paediatric) · Atypical Antipsychotic — Autism Spectrum Disorder / Schizophrenia / Tic Disorders
- Aciclovir 800mg Tablets (Ramsay Hunt Syndrome / Herpes Zoster Oticus) · Antiviral — nucleoside analogue (herpes zoster treatment)
- Pramipexole (Restless Legs Syndrome — Elderly) · Dopamine Agonist (D2/D3 Receptor)
- Docusate Sodium · Faecal Softener / Stimulant Laxative
- Sodium Picosulfate · Stimulant Laxative / Bowel Preparation Agent
- Citric acid · Bowel preparation component
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.